نتایج جستجو برای: targeted radiation therapy microdosimetry

تعداد نتایج: 973977  

Catherine Patte, Odile Oberlin,

Hodgkin lymphoma (HL) accounts for about 10% of all childhood cancers. Five-year survival rates with modern therapies are now approaching >90-95% as a consequence of its significant sensitivity to both chemotherapy and radiation. The current challenge is to determine how much therapy is needed to improve survival and how to adapt treatment to the patient to prevent these long term toxicities. T...

2008
Brian D. Lawenda Tammy E. Mondry

Radiation therapy has been an effective therapeutic modality in the management of both benign and malignant tumors for over a century. The science and technology surrounding the deliv-ery of this targeted treatment has significantly improved our ability to not only control tumors, but to also minimize the untoward complications of irradiating normal tissues. Advances in radia-tion and surgical ...

Journal: :Radiation Protection Dosimetry 1990

Journal: :The Journal of clinical investigation 2011
Xiaohua Ni Yonggang Zhang Judit Ribas Wasim H Chowdhury Mark Castanares Zhewei Zhang Marikki Laiho Theodore L DeWeese Shawn E Lupold

Dose-escalated radiation therapy for localized prostate cancer (PCa) has a clear therapeutic benefit; however, escalated doses may also increase injury to noncancerous tissues. Radiosensitizing agents can improve ionizing radiation (IR) potency, but without targeted delivery, these agents will also sensitize surrounding normal tissues. Here we describe the development of prostate-targeted RNAi ...

2015
Jonathan L. Dean Andrew R. Clark Christopher D. Buckley Jeremy Saklatvala Nicholas A. Morrice Claudia Monaco Helen E. Cunliffe Tina Tang Dalya R. Rosner Ewan A. Ross Tim Smallie Qize Ding John D. O'Neil John D. O’Neil Iva Klevernic Adam F. Cunningham

2012
Andrea Sartore-Bianchi Steffen Fieuws Silvio Veronese Mauro Moroni Nicola Personeni Milo Frattini Valter Torri Federico Cappuzzo Sara Vander Borght Vittoria Martin Margaret Skokan Armando Santoro Marcello Gambacorta Sabine Tejpar Marileila Varella-Garcia Salvatore Siena

Aims Epidermal growth factor receptor (EGFR) gene copy number evaluated by fluorescence in situ hybridisation (FISH) can discriminate among KRAS wild-type patients those with better outcome to EGFR-targeted therapy in metastatic colorectal cancer, further enhancing selection of patients. Nevertheless, enumeration of gene copies is challenging and the lack of analytical standardisation has limit...

2012
James S. Wilmott Richard A. Scolyer Georgina V. Long Peter Hersey

Recently, a CTLA-4 antibody and BRAF inhibitors showed survival benefits in advance melanoma treatment. The documentation of immune infiltrates in melanomas early during BRAF inhibitor therapy provides a scientific rationale for combination therapy with both treatments with possible synergistic benefits. This commentary reviews immune responses induced by BRAF inhibitors.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید